MedPath

Comparison of Dual Amoxicillin/Vonoprazan Therapy and Triple Vonoprazan/Amoxicillin/Clarithromycin or Metronidazole Therapy for H. Pylori Eradicatio

Not Applicable
Recruiting
Conditions
H. pylori infection
Registration Number
JPRN-UMIN000022963
Lead Sponsor
Hamamatsu University School of Medicine
Brief Summary

On going

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

Patients uninfected with H. pylori Patients who have ever failed in eradication more than two times. Patients from whom IC cannot be obtained Patients considered not eligible to the study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eradication rate of H. pylori Success or failure of eradication is assessed by thr 13C-urea breath test at 4 - 8 weeks after the eradication therapy
Secondary Outcome Measures
NameTimeMethod
Adverse events
© Copyright 2025. All Rights Reserved by MedPath